Robert Leech

Neuroscientist

Data updated

Papers

15 publications

Trials

0 clinical trials

Links

Research Footprint

Robert Leech appears in 15 tracked papers (2012–2023), most studied alongside Psilocybin, LSD and DMT, across Neuroimaging & Brain Measures, Healthy Volunteers and Schizophrenia.

Most-cited paper: The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs (1269 citations).

Frequent co-authors: Robin Carhart-Harris, David Nutt and Leor Roseman.

Publication Landscape

How the 15 papers Blossom tracks for Robert Leech line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.

How has Robert Leech's publishing grown?

Sourced

Tracked papers by publication year. Click a year for the running total.

3papers published in 2016

+200% vs 2015

8 published by 2016

Browse papers

Don't read as total output: only the 15 of 15 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.

What does Robert Leech publish on?

Sourced

Tracked papers per topic. Orange marks the largest research focus.

Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.

Where does Robert Leech publish?

Sourced

Tracked papers per journal. Orange marks the most-used journal.

Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.

Background & Research

Robert Leech is a neuroscientist whose work centres on applying neuroimaging methods to characterise how psychedelic compounds alter large‑scale brain dynamics and conscious experience. He has collaborated with leading teams in the field to study healthy volunteers administered LSD, psilocybin and DMT using fMRI, EEG–fMRI and connectivity analyses, and has helped link acute phenomenology (for example ego‑dissolution) to measurable changes in global functional connectivity. His methodological focus includes network and connectivity metrics and their interpretation in the context of altered states.

Leech's publications and collaborative projects have informed hypotheses about the neural basis of psychedelic states and their relevance to psychopathology and psychotherapy — for example work that connects psilocybin‑induced connectivity changes to models of early psychosis and studies that consider implications for psychedelic‑assisted psychotherapy. He is frequently listed as a co‑author on influential neuroimaging papers in the field and has contributed to efforts to integrate neurobiological, clinical and theoretical perspectives on consciousness and therapeutic mechanisms of psychedelics.

Key Impact

Noted for applying advanced neuroimaging and functional‑connectivity analyses to characterize brain network changes induced by classical psychedelics and for contributions to theories of altered conscious states.

15

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

34 collaborators· click a node to visit their profile

Full network →

Collaboration Network

See Robert Leech's full collaboration network, shared papers, and research connections.

Affiliations

Institutions, companies, and organisations Robert Leech is associated with.